354
O. P. Pereshivko et al.
LETTER
Savaliya, B.; De Weerdt, A.; De Coster, D.; Shah, A.; Van
der Eycken, E. V.; De Vos, D. E.; Vanderleyden, J.; De
Keersmaecker, S. C. J. J. Med. Chem. 2011, 54, 472.
(f) Ermolat’ev, D. S.; Bariwal, J. B.; Steenackers, H. P. L.;
De Keersmaecker, S. C. J.; Van der Eycken, E. V. Angew.
Chem. Int. Ed. 2010, 49, 9465. (g) Pereshivko, O. P.;
Peshkov, V. A.; Ermolat’ev, D. S.; Van Hove, S.; Van
Hecke, K.; Van Meervelt, L.; Van der Eycken, E. V.
Synthesis 2011, 1587.
Supporting Information for this article is available online at
m
iotSrat
ungIifoop
r
t
References and Notes
(1) The authors contributed equally to this work.
(2) For selected reviews covering different aspects of
isocyanide-based multicomponent reactions, see:
(a) Dömling, A.; Ugi, I. Angew. Chem. Int. Ed. 2000, 39,
3168. (b) Dömling, A. Chem. Rev. 2006, 106, 17. (c) De
Moliner, F.; Banfi, L.; Riva, R.; Basso, A. Comb. Chem.
High Throughput Screening 2011, 14, 782. (d) Elders, N.;
Ruijter, E.; Nenajdenko, V. G.; Orru, R. V. A. Top.
Heterocycl. Chem. 2010, 23, 129. (e) van Berkel, S. S.;
Bögels, B. G. M.; Wijdeven, M. A.; Westermann, B.; Rutjes,
F. P. J. T. Eur. J. Org. Chem. 2012, 3543. (f) El Kaim, L.;
Grimaud, L. Tetrahedron 2009, 65, 2153. (g) Ivachtchenko,
A. V.; Ivanenkov, Ya. A.; Kysil, V. M.; Krasavin, M.; Ilyin,
A. P. Russ. Chem. Rev. 2010, 79, 787.
(8) For our advancements in the elaboration of the 2-
aminoimidazole core, see: Modha, S. G.; Mehta, V. P.;
Ermolat’ev, D. S.; Balzarini, J.; Van Hecke, K.; Van
Meervelt, L.; Van der Eycken, E. Mol. Diversity 2010, 14,
767.
(9) Guchhait, S. K.; Madaan, C.; Thakkar, B. S. Synthesis 2009,
3293.
(10) Parchinsky, V. Z.; Shuvalova, O.; Ushakova, O.;
Kravchenko, D. V.; Krasavin, M. Tetrahedron Lett. 2006,
47, 947.
(11) (a) Mironov, M. A.; Tokareva, M. I.; Ivantsova, M. N.;
Mokrushin, V. S. Russ. Chem. Bull., Int. Ed. 2006, 55, 1835.
(b) Rahmati, A.; Kouzehrash, M. A. Synthesis 2011, 2913.
(12) Microwave-Assisted Groebke–Blackburn–Bienaymé
Reaction; Typical Procedure for 1-Benzyl-N-tert-butyl-
2,6-diphenyl-1H-imidazo[1,2-a]imidazol-5-amine (4a):
To a microwave vial equipped with a magnetic stir bar
containing 1a (75 mg, 0.3 mmol) and p-toluenesulfonic acid
hydrate (11 mg, 0.06 mmol), anhydrous toluene (1 mL), 2a
(38 mg, 0.36 mmol) and 3a (37 mg, 0.45 mmol) were
consecutively added. The reaction vessel was sealed and
irradiated in the cavity of a CEM-Discover microwave
reactor at a set temperature of 110 °C for 30 min. Upon
completion of the reaction, the vial was cooled with a stream
of air. The resulting reaction mixture was diluted with
EtOAc (50 mL), thoroughly washed with 1 M HCl
(2 × 50 mL) and sat. aq Na2CO3 (50 mL), dried over
Na2SO4, and concentrated under reduced pressure. The
crude product was dissolved in EtOAc (5 mL) and subjected
to flash chromatography [silica (25 g); EtOAc–heptane, 3:7]
to give pure 4a (87 mg, 69%). 1H NMR (300 MHz, CDCl3):
δ = 8.07–7.95 (m, 2 H), 7.41–7.26 (m, 7 H), 7.25–7.10 (m,
6 H), 6.94 (s, 1 H), 5.22 (s, 2 H), 2.90 (br s, 1 H), 1.12 (s,
9 H); 13C NMR (CDCl3, 75 MHz): δ = 145.5, 137.4, 136.3,
136.2, 133.3, 129.5, 128.9, 128.7, 128.62, 128.56, 128.47,
128.0, 127.4, 127.3, 126.0, 120.1, 102.5, 55.6, 47.0, 30.3;
HRMS (EI): m/z calcd for C28H28N4: 420.2314; found:
420.2281.
(3) For selected reviews on post-condensation transformations,
see: (a) Banfi, L.; Basso, A.; Riva, R. Top. Heterocycl.
Chem. 2010, 23, 1. (b) Banfi, L.; Riva, R.; Basso, A. Synlett
2010, 23.
(4) (a) Groebke, K.; Weber, L.; Mehlin, F. Synlett 1998, 661.
(b) Blackburn, C.; Guan, B.; Fleming, P.; Shiosaki, K.; Tsai,
S. Tetrahedron Lett. 1998, 39, 3635. (c) Bienaymé, H.;
Bouzid, K. Angew. Chem. Int. Ed. 1998, 37, 2234.
(5) For selected examples, see: (a) Krasavin, M.; Tsirulnikov,
S.; Nikulnikov, M.; Kysil, V.; Ivachtchenko, A. Tetrahedron
Lett. 2008, 49, 5241. (b) Guchhait, S. K.; Madaan, C.
Tetrahedron Lett. 2011, 52, 56. (c) Lyon, M. A.; Kercher, T.
S. Org. Lett. 2004, 6, 4989. (d) Schwerkooke, J.; Masquelin,
T.; Perun, T.; Hulme, C. Tetrahedron Lett. 2005, 46, 8355.
(e) Parchinsky, V. Z.; Koleda, V. V.; Schuvalova, O.;
Kravchenko, D. V.; Krasavin, M. Tetrahedron Lett. 2006,
47, 6891. (f) Sandulenko, Y.; Komarov, A.; Rufanov, K.;
Krasavin, M. Tetrahedron Lett. 2008, 49, 5990.
(g) Rousseau, A. L.; Matlaba, P.; Parkinson, C. J.
Tetrahedron Lett. 2007, 48, 4079. (h) Lamberth, C. Synlett
2011, 1740. (i) Sharma, A.; Li, H.-y. Synlett 2011, 1407.
(j) Guasconi, M.; Lu, X.; Massarotti, A.; Caldarelli, A.;
Ciraolo, E.; Tron, G. C.; Hirsch, E.; Sorba, G.; Pirali, T. Org.
Biomol. Chem. 2011, 9, 4144.
(6) In some literature reports, the formation of two isomeric
azine-fused aminoimidazole products was described, see:
(a) Mandair, G. S.; Light, M.; Russell, A.; Hursthouse, M.;
Bradley, M. Tetrahedron Lett. 2002, 43, 4267.
(13) CAUTION! The acidic aqueous workup was necessary in
most cases to decompose imine 5, which was otherwise
difficult to separate from the desired product 4 (Scheme 1).
See the Supporting Information for details.
(b) Nenadjenko, V. G.; Reznichenko, A. L.; Balenkova, E.
S. Russ. Chem. Bull., Int. Ed. 2007, 56, 560. (c) Guchhait, S.
K.; Madaan, C. Synlett 2009, 628.
(7) For our advancements in the synthesis of polysubstituted 2-
aminoimidazole derivatives, see: (a) Ermolat’ev, D. S.;
Babaev, E. V.; Van der Eycken, E. V. Org. Lett. 2006, 8,
5781. (b) Ermolat’ev, D. S.; Alifanov, V. L.; Rybakov, V.
B.; Babaev, E. V.; Van der Eycken, E. V. Synthesis 2008,
2083. (c) Ermolat’ev, D. S.; Van der Eycken, E. V. J. Org.
Chem. 2008, 73, 6691. (d) Ermolat’ev, D. S.; Svidritzky, E.
P.; Babaev, E. V.; Van der Eycken, E. Tetrahedron Lett.
2009, 50, 5218. (e) Steenackers, H. P. L.; Ermolat’ev, D. S.;
R2
R2
R1
R1
H+
N
N
R3
N
NH2
+
O
R3
2
N
N
5
1
Scheme 1
Synlett 2013, 24, 351–354
© Georg Thieme Verlag Stuttgart · New York